Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

53.32
Delayed Data
As of 4:02pm ET
 +0.90 / +1.72%
Today’s Change
32.83
Today|||52-Week Range
53.41
+48.69%
Year-to-Date

Today’s Trading

Previous close52.42
Today’s open52.68
Day’s range52.66 - 53.41
Volume1,274,574
Average volume (3 months)1,856,937
Market cap$103.1B
Data as of 4:02pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.52%
Revenue growth (last year)+3.81%
P/E ratio21.8
Price/Sales5.48
Price/Book20.44

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.76+1.38%
LLYEli Lilly and Co+0.04+0.05%
BMYBristol-Myers Squibb+0.26+0.41%
GSKGlaxoSmithKline+0.21+0.59%
Data as of 4:02pm ET, 12/12/2017

Financials

Next reporting dateFebruary 1, 2018
EPS forecast (this quarter)$0.55
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts